We aim to influence policy developments so that researchers can be as effective as possible and health can be improved.

We work with a wide range of partners – including governments, research funders, learned societies, charities and commercial organisations – in the UK, Europe and globally. 

Ed Whiting

Director of Policy and Chief of Staff

Natalie Paloma-Solis

Executive Assistant to Ed Whiting

Beth Thompson

Head of UK and EU Policy

Michelle Marshall

PA and Team Coordinator

Stuart Pritchard

EU and Public Affairs Manager

Contact about:

Brexit, public affairs, relationship management, EU health and research policy.

Sam Alvis

Policy Officer

Contact about:

gene editingresearch involving animals, EU funding and regulation.

Natalie Banner

Policy Adviser

Ben Bleasdale

Policy Adviser

Contact about:

UK research investment, funding structures, Research Excellence Framework, What’s it Worth studies.

Joe Clift

Policy Adviser

Contact about:

emerging science and technologies, regulation.

Amelia Dearman

Policy Officer

Contact about:

immigration, innovation policy, All-Party Parliamentary Group on Medical Research, parliamentary communications, diversity, education and skills.

Sarah Rappaport

Policy Adviser

Contact about:

emerging science and technologies, mitochondrial donation, regulation of clinical trials, research in the NHS, research involving embryos.

Alex Harris

Head of Global Policy

Jack Snow

Team Coordinator

Contact about:

general enquiries for Global Policy, cultural engagement.

Will Hall

Policy Manager

Contact about:

access to healthcare interventions (general), epidemic preparedness, sustainable development goals.

Anne Hoppe

Policy Manager

Contact about:

access to healthcare interventions (products), research uptake.

Olivia Allen

Policy Officer

Contact about:

access to healthcare interventions (general), research uptake.

Heather Browett

Policy Officer

Contact about:

emerging science and technologies, research uptake.

Rachael Crockett

Policy Adviser

Contact about:

access to healthcare interventions (general), vaccines, sustainable development goals.

James Hynard

Policy Officer

Contact about:

access to healthcare interventions (general), drug-resistant infections, sustainable development goals.

Alice Jamieson

Policy Officer

Contact about:

epidemic preparedness, sustainable development goals, vaccines.

Diogo Martins

Policy Officer (on secondment)

Contact about:


Sophie Mathewson

Policy Adviser

Contact about:

access to healthcare interventions (products), epidemic preparedness.

Anna Ruddock

Policy Adviser

Contact about:

research uptake.

Our work

Good clinical practice guidelines

New clinical practice guidelines are urgently needed for trials where the current guidelines are not fit for purpose.

Access to healthcare interventions

Everyone should have access to the life-changing benefits of medicines and other healthcare interventions, like vaccines, diagnostics and therapies.

Open research

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.

Brexit and the EU

We're working with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.

Emerging science and technologies

Emerging science and technologies, such as human genome editing and gene drive, could provide new solutions to health problems.

Patient data in research

Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.

Government investment in research

Government investment plays an important part in supporting scientific excellence in the UK.

Data sharing in public health emergencies

Research is an essential part of being ready for and responding to public health emergencies.

Data Protection Regulation

The European General Data Protection Regulation was agreed in April 2016 and took effect from 25 May 2018.

EU copyright law reform

The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.

Research involving animals

Almost every major breakthrough in human and veterinary medicine has depended on the use of animals to research, develop or test new therapies.

Mitochondrial donation

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

EU medical devices regulations

The European Union is revising regulations governing the manufacture and sale of medical devices.

Research practice

Good research practice is one of the foundations of high-quality research.

Expert Advisory Group on Data Access

The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.

Accelerated Access Review

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.


A woman scientist handling test tubes at UK Biobank.

Opinion | 19 February 2019

Open access and Plan S: how Wellcome is tackling four key concerns by Robert Kiley, David Carr

A man being vaccinated in an Ebola vaccine trial in Liberia

Opinion | 15 February 2019

This is a pivotal moment for clinical trial regulations by Beth Thompson

More news


Exploring good clinical practice in clinical trials [PDF 124KB]

  • February 2019

Our workshop with the Gates Foundation and the Academy of Medical Sciences looked at how the current guidelines for clinical trials could be improved, and possible alternative approaches.

Brexit and Beyond: clinical trials [PDF 969KB]

  • February 2019

We explore options for the regulation of clinical trials in the UK after Brexit.

Data policy models for funding bodies [PDF 858KB]

  • December 2018

How funders can work with the research community to improve data access, governance and management.

More reports

Briefings and responses